Although evidence demonstrating the efficacy of computed tomographic lung screening (CTLS) is established, global uptake of CTLS has been slow, and the optimal methods of implementing CTLS have not been determined and may vary in different populations. One of the pieces of the puzzle that has needed…
This systematic review and meta-analysis examines the presence and incidence of discontinuation symptoms in individuals who stop taking antidepressants.
This case series study examines the use and outcomes of total neoadjuvant therapy in routine practice for patients with rectal cancer.
This cohort and nested case-control study among CARDIA (Coronary Artery Risk Development in Young Adults) participants evaluates trajectories of moderate to vigorous physical activity across…
This cohort study evaluates the association of glucagon-like peptide 1 receptor agonists (GLP-1RAs) semaglutide and tirzepatide with incidence of neurodegenerative and cerebrovascular diseases in patients…
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
This Review summarizes current evidence on colorectal, pancreatic, and esophagogastric cancers among individuals aged 18 to 49 years.
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This study uses a microsimulation model to understand broader consequences of the 2025 Budget Reconciliation Bill on health outcomes, health systems, and local economies.
This cohort study conducted in Ontario, Canada, evaluates the risk of developing neovascular age-related macular degeneration associated with the use of glucagon-like peptide-1 receptor agonists…
This case-control study examines glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure and prevalence of nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes,…
